Compared with sporadic breast cancer, patients with germline BRCA PVs are more likely to develop contralateral breast cancer, the cumulative risk 20 years after breast cancer diagnosis was 40% for BRCA1 and 26% for BRCA2 (17). This evidence concerns the gene BRCA1 and breast cancer.